Skip to content

Author

Glaucius Oliva

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Insights into Inhibitory Effects of Lapachol against Zika Virus

The reemergence of Zika virus (ZIKV) in 2015 and its association with severe neurological manifestations highlighted the urgent need for effective antiviral therapies, which, despite extensive efforts, remain unavailable. Lapachol, a 1,4-naphthoquinone compound abundant in Brazilian plant species, seems to be a promi...

Stephanie Paola Borjas Reyes, N. Cassani, João Victor Rodrigues Dutra et al. · 0 citations
Open access Oct 2026

Synthetic Flavonoid Analogues as CatB/CatL Inhibitors with Potential Anti-SARS-CoV-2 Activity

The COVID-19 pandemic profoundly affected global public health. Intensive efforts have led to the development of vaccines and antiviral drugs. However, the emergence of SARS-CoV-2 variants has raised concerns about resistance to therapies, making the exploration of alternative molecular pathways a promising strategy....

E. Lourenço, Marli de F. C. Emiliano, Silvana Ribeiro et al. · 0 citations
Open access Aug 2026

Pyridin-3-carbohydrazide strongly impairs Mayaro and Chikungunya virus replication in vitro

The data suggest that P-3-C exhibits a potential multitarget mechanism of action and highlight its antiviral activity against different alphavirus strains; however, this efficacy could be dependent on the cell line used.

N. Contreras, N. Cassani, Mikaela dos Santos Marinho et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.